<DOC>
	<DOCNO>NCT00429169</DOCNO>
	<brief_summary>The primary study compare effectiveness suicidal ideation and/or behavior two antidepressant medication depress patient attempted suicide currently experience suicidal thought complete . A secondary study component use functional magnetic resonance imaging ( fMRI ) investigate different medication effect reward process sample ongoing .</brief_summary>
	<brief_title>Paroxetine/Bupropion Suicide Attempters/Ideators With Major Depression</brief_title>
	<detailed_description>Major depressive disorder ( MDD ) common serious psychiatric illness . It among lead cause disability psychiatric disorder often associate suicide . The treatment MDD antidepressant medication remain largely trial error . Little empirical evidence exists guide treatment MDD suicide risk major factor . Selective serotonin reuptake inhibitor ( SSRIs ) type antidepressant medication work increase amount serotonin , natural substance brain help maintain mental balance . The study compare effectiveness paroxetine , SSRI , versus bupropion , non-SSRI , suicidal ideation and/or behavior depress patient past suicide attempt and/or current suicidal thought . Results complete primary study publish ( Grunebaum MF et al . Neuropsychopharmacology . 2012 Feb ; 37 ( 3 ) :697-706 ) . In ongoing secondary neuro-imaging component study , Participants randomly assign either paroxetine bupropion treatment 8 week fMRI scan involve reward processing task baseline Week 8 . Weekly study visit include interview psychologist , self-report scale , medication monitoring . All participant offer 4 additional month open clinical treatment . If original medication assignment prove ineffective , participant option switch another medication . After complete study , participant refer ongoing treatment .</detailed_description>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Depressive Disorder , Major</mesh_term>
	<mesh_term>Suicide</mesh_term>
	<mesh_term>Paroxetine</mesh_term>
	<mesh_term>Bupropion</mesh_term>
	<criteria>Currently suffer major depressive episode ( unipolar ) History past suicide attempt score great 2 Hamilton Depression Rating Scale ( HDRS ) item # 3 ( suicide ) inperson screen interview . Patients suicidal plan intent enrol inpatient independent inpatient treatment team agree . Patients 60 year age old must score least 25 MMSE screening . Patients 60 year age old must normal ECG within past year . Any following condition : bipolar disorder ; current psychotic symptom ; bulimia anorexia current within past year , current purge least twice week three month ; already take selective serotonin reuptake inhibitor ( SSRIs ) bupropion indication ( anxiety disorder ) Primary disorder anxiety disorder ( e.g. , panic disorder , general anxiety disorder , obsessive compulsive disorder , social anxiety disorder ) , secondary depression Drug alcohol dependence within 6 month prior study entry ( current drug alcohol abuse may permit study official determine abuse less importance major depressive episode ) Systolic blood pressure great equal 140 mm Hg diastolic blood pressure great equal 90 mm Hg Significant active physical illness , particularly may affect brain serotonergic system ( e.g. , blood dyscrasia lymphoma , hypersplenism , endocrinopathies , kidney failure , severe chronic obstructive lung disease , autonomic neuropathy , active malignancy ) Active medical problem Requires antipsychotic medication History hypomania mania take antidepressant Any condition may make use SSRI bupropion medically inadvisable Currently use Zyban Failure respond adequate trial three SSRIs , paroxetine , bupropion within 2 year prior study entry ( failure respond therapeutic trial define least 2/3 maximal daily dose [ PDR ] least 6 week ) Pregnant , breastfeeding , plan become pregnant course study participation Currently effective treatment , require adjunctive antipsychotic mood stabilize medication , unlikely respond single agent treatment depression Patients ferrous metal implant body , history claustrophobia precludes MRI , exclude . Patients assess unlikely tolerate maximum 2week delay start treatment .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>December 2012</verification_date>
	<keyword>Major Depressive Disorder</keyword>
	<keyword>MDD</keyword>
</DOC>